Oragenics, Inc. operates as a development-stage company, which engages in research and development of potential therapies to fight infectious diseases including coronaviruses and multidrug-resistant organisms. The company is headquartered in Lakewood Ranch, Florida and currently employs 3 full-time employees. The company went IPO on 2003-07-09. The company is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company focuses on nasal delivery of pharmaceutical medications in neurology and fighting infectious diseases, including drug candidates for treating mild traumatic brain injury (mTBI or Concussion), and for treating Niemann Pick Disease Type C (NPC), and proprietary powder formulation and an intranasal delivery device. Its lead product, ONP-002, is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The company is also focused on developing medical products that treat brain related illnesses and diseases (the Neurology Assets). Its other product candidate, ONP-001, is in its early stage and clinical trials.
OGEN'ün son EPS'si beklentilerle karşılaştırıldığında nasıldı?
Oragenics Inc'in en son EPS'si $ olup, $ beklentilerini .
Oragenics Inc OGEN'ün son çeyrekteki geliri nasıl performans gösterdi?
Oragenics Inc'in son çeyrek geliri $
Oragenics Inc'in gelir tahmini nedir?
Wall Street analistine göre, Oragenics Inc'in gelir tahmini $ ile $ arasında değişmektedir.
Oragenics Inc'in kazanç kalite puanı nedir?
Oragenics Inc'in kazanç kalite puanı B+/56.30948'dir. Puan, karlılık, büyüme, nakit üretimi ve sermaye tahsisi ile kaldıraç olmak üzere dört boyuta dayanır.
Oragenics Inc kazançlarını ne zaman rapor eder?
Oragenics Inc'in bir sonraki kazanç raporu 2026-06-10'te bekleniyor
Oragenics Inc'in beklenen kazançları nelerdir?
Wall Street analistlerine göre Oragenics Inc'in beklenen kazançları $'dir.
Oragenics Inc kazanç beklentilerini aştı mı?
Oragenics Inc'in son kazançları $ olup, beklentileri .